BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23174025)

  • 1. Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy.
    Barth H; Raghuraman S
    Crit Rev Microbiol; 2014 Nov; 40(4):360-8. PubMed ID: 23174025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecules in focus: indoleamine 2,3-dioxygenase.
    King NJ; Thomas SR
    Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
    Fallarino F; Grohmann U; Puccetti P
    Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
    Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
    Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.
    Tan PH; Bharath AK
    Expert Opin Ther Targets; 2009 Aug; 13(8):987-1012. PubMed ID: 19534572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDO expression by dendritic cells: tolerance and tryptophan catabolism.
    Mellor AL; Munn DH
    Nat Rev Immunol; 2004 Oct; 4(10):762-74. PubMed ID: 15459668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-dioxygenase in transplantation.
    Mulley WR; Nikolic-Paterson DJ
    Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO-expressing regulatory dendritic cells in cancer and chronic infection.
    Popov A; Schultze JL
    J Mol Med (Berl); 2008 Feb; 86(2):145-60. PubMed ID: 17876564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
    Di Pucchio T; Danese S; De Cristofaro R; Rutella S
    Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence.
    Luukkainen A; Toppila-Salmi S
    Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):37-44. PubMed ID: 23128419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?
    Adu-Gyamfi CG; Savulescu D; George JA; Suchard MS
    Front Cell Infect Microbiol; 2019; 9():372. PubMed ID: 31737575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
    Reddy SV; Reddy KT; Kumari VV; Basha SH
    J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Opin Organ Transplant; 2008 Feb; 13(1):10-5. PubMed ID: 18660700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tryptophan catabolism in acquisition and effector function of memory T cells.
    Dai H; Dai Z
    Curr Opin Organ Transplant; 2008 Feb; 13(1):31-5. PubMed ID: 18660704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
    Orabona C; Grohmann U
    Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
    Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
    Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of IDO in organ transplantation: promises and difficulties.
    Löb S; Königsrainer A
    Int Rev Immunol; 2009; 28(3-4):185-206. PubMed ID: 19811321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.